All
Why Are Survivorship Care Plans Not Being Received?
May 12th 2018The transition into survivorship is no easy feat. Emotions are mixed, long-term and late side effects may kick in and follow-up care appointments start. But are survivors getting the best possible care after cancer treatment? That’s still up for debate.
FDA Approves Darzalex Combination for Newly Diagnosed Multiple Myeloma
May 8th 2018The Food and Drug Administration (FDA) granted approval to Darzalex (daratumumab) in combination with Velcade (bortezomib), melphalan and prednisone – also known as VMP – for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant (ASCT).
Tecentriq Granted Priority Review to Treat Lung Cancer
May 7th 2018The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Tecentriq (atezolizumab) to be used in combination with Avastin (bevacizumab), carboplatin and paclitaxel for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC).